Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma?
about
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma.A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomasPixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.Rituximab, gemcitabine and oxaliplatin: an effective regimen in patients with refractory and relapsing mantle cell lymphoma.
P2860
Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma?
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Rituximab plus gemcitabine: a ...... essive non Hodgkin's lymphoma?
@ast
Rituximab plus gemcitabine: a ...... essive non Hodgkin's lymphoma?
@en
type
label
Rituximab plus gemcitabine: a ...... essive non Hodgkin's lymphoma?
@ast
Rituximab plus gemcitabine: a ...... essive non Hodgkin's lymphoma?
@en
prefLabel
Rituximab plus gemcitabine: a ...... essive non Hodgkin's lymphoma?
@ast
Rituximab plus gemcitabine: a ...... essive non Hodgkin's lymphoma?
@en
P2093
P2860
P1433
P1476
Rituximab plus gemcitabine: a ...... essive non Hodgkin's lymphoma?
@en
P2093
P2860
P356
10.1080/10428190400007540
P577
2005-01-01T00:00:00Z